Navigation Links
Global Rheumatoid Arthritis Drugs Market 2014-2018
Date:7/28/2014

DUBLIN, July 28, 2014 /PRNewswire/ -- Research and Markets has announced the addition of the "Global Rheumatoid Arthritis Drugs Market 2014-2018" report to their offering.

http://photos.prnewswire.com/prnh/20130307/600769

RA is a chronic disease that leads to inflammation and pain in the human body's joints such as wrists, fingers, knees, feet, and ankles. In addition, it causes inflammation of the tissues that surround the joints and in other organs.

The symptoms of RA begin slowly, usually just mild pain around the joints coupled with stiffness and fatigue, and in the later stages it causes inflammation of the joints. It can occur at any age, even in children, which is called juvenile arthritis. The disease is three times more common in women than in men. Genetic and environmental elements are known to contribute in the development of RA.

The analysts forecast the Global Rheumatoid Arthritis Drugs market will grow at a CAGR of 4.09 percent over the period 2013-2018.

Key Topics Covered:

01. Executive Summary

02. List of Abbreviations

03. Scope of the Report

04. Market Research Methodology

05. Introduction

06. Market Landscape

07. Competitive Assessment of Top Drugs

08. Five Forces Analysis

09. Market Segmentation by Category

10. Geographical Segmentation

11. Buying Criteria

12. Rate of Incidence and Prevalence

13. Pipeline Snapshot

14. Market Growth Drivers

15. Drivers and their Impact

16. Market Challenges

17. Impact of Drivers and Challenges

18. Market Trends

19. Trends and their Impact

20. Vendor Landscape

21. Key Vendor Analysis

22. Other Reports in this Series

Companies Mentioned:

  • AbbVie Inc.
  • Amgen Inc.
  • Bristol-Myers Squibb Co.
  • F. Hoffmann-La Roche Ltd.
  • Janssen Pharmaceuticals Inc.
  • Pfizer Inc.
  • AB Science SA
  • Astellas Pharma Inc.
  • AstraZeneca plc
  • Biogen Idec Inc.
  • Boehringer Ingelheim GmbH
  • Celgene Corp.
  • Daiichi Sankyo Co. Ltd.
  • Eli Lilly & Co.
  • GE Healthcare Co.
  • Genmab A/S
  • GSK plc
  • Incyte Corp.
  • Merck & Co. Inc.
  • Mitsubishi Tanabe Pharma Corp.
  • Novartis AG
  • Novo Nordisk A/S
  • Rigel Pharmaceuticals Inc.
  • Sanofi
  • Takeda Pharmaceutical Co. Ltd.
  • UCB SA
  • Vertex Pharmaceuticals Inc.

For more information visit http://www.researchandmarkets.com/research/69ldtg/global_rheumatoid

Media Contact: Laura Wood, +353-1-481-1716, press@researchandmarkets.net


'/>"/>
SOURCE Research and Markets
Copyright©2014 PR Newswire.
All rights reserved

Related medicine technology :

1. Global and Chinese Vardenafil Industry (CAS 224785-90-4) 2019 Forecasts
2. Contract Research Organization WCCT Global Welcomes Peter Nieto as Vice President of Business Development
3. Global Insulin Market Expected to Reach USD 32.24 Billion Globally in 2019: Transparency Market Research
4. Global Ophthalmic Diagnostic Devices Market 2014-2018: Key Vendors are Alcon, Carl Zeiss, Haag-Streit and Topcon
5. Hemodialysis Machine Industry for Global and Chinese Markets Forecast to 2019
6. Global Diagnostic Electrocardiograph (Resting, Stress, Holter Monitor) (ECG) Market - Forecast to 2020
7. Global Electrophysiology Ablation Catheters Market 2014-2018: Key Vendors are Boston Scientific, Johnson & Johnson, Medtronic and St. Jude Medical
8. Prepackaged Medical Kits and Trays - Global Strategic Business Report: Updated 2014 Report
9. Emulsifiers - Global Strategic Business Report: Updated 2014 Report
10. Global Digital X-Ray Market 2018 Analysis and Forecast In New Research Report Available at RnRMarketResearch.com
11. Global Cell Culture (Bioreactor, Incubator, Centrifuge) Market - Forecast to 2018
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:6/26/2016)... , June 27, 2016 Jazz Pharmaceuticals ... waiting period under the Hart-Scott-Rodino Antitrust Improvements Act of ... acquisition of Celator Pharmaceuticals, Inc. ("Celator"; Nasdaq: ... p.m. (Eastern Daylight Time). As previously announced ... into a definitive merger agreement under which Jazz Pharmaceuticals ...
(Date:6/24/2016)... HILL, N.C. , June 24, 2016 /PRNewswire/ ... healthcare decisions and regulators/payers have placed more emphasis ... new environment, patient support programs in the pharmaceutical ... for patients, medications. Consequently, pharmaceutical companies are focusing ... ensure they are providing products and services that ...
(Date:6/24/2016)...   Bay Area Lyme Foundation , collaborating ... for Tick Borne Illness , Harvard Medical School ... Medicine, University of California, Berkeley, and the Veterans ... finalists of Lyme Innovation , the first ... scientists, clinicians, researchers, entrepreneurs, and investors from several ...
Breaking Medicine Technology:
(Date:6/27/2016)... ... June 27, 2016 , ... ... today announced its strategic partnership with Connance, a healthcare industry leader providing ... companies’ proven, proprietary technology combine to provide health systems, hospitals and ambulatory ...
(Date:6/26/2016)... ... June 26, 2016 , ... Pixel Film Studios Released ProSlice Levels, a Media ... give their videos a whole new perspective by using the title layers in ... Studios. , ProSlice Levels contains over 30 Different presets to choose from. ...
(Date:6/25/2016)... ... 2016 , ... Austin residents seeking Mohs surgery services, can now turn to ... Dr. Russell Peckham for medical and surgical dermatology. , Dr. Dorsey brings specialization to ... fellowship in Mohs Micrographic Surgery completed by Dr. Dorsey was under the direction of ...
(Date:6/25/2016)... ... June 25, 2016 , ... Dr. ... from injury. Recently, he has implemented orthobiologic procedures as a method for treating ... one of the first doctors to perform the treatment. Orthobiologics are substances that ...
(Date:6/24/2016)... Michigan (PRWEB) , ... June 24, 2016 , ... June ... about the dangers associated with chronic pain and the benefits of holistic treatments, ... individuals who are suffering with Sickle Cell Disease. , Sickle Cell Disease (SCD) is ...
Breaking Medicine News(10 mins):